📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! Tell us what works, what doesn't, and how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community. Please send your feedback to gateway@ukri.org by 11 August 2025.

Statistical consideration when adding new arms to ongoing clinical trials: the potentials and the caveats. (2021)

First Author: Lee KM

Attributed to: Developing efficient perpetual platform trials to study multiple treatments and multiple biomarkers funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s13063-021-05150-7

PubMed Identifier: 33691748

Publication URI: http://europepmc.org/abstract/MED/33691748

Type: Journal Article/Review

Volume: 22

Parent Publication: Trials

Issue: 1

ISSN: 1745-6215